Role of peroxynitrite-modified H2A histone in the induction and progression of rheumatoid arthritis

Scandinavian Journal of Rheumatology

Volumn 41, Issue 6, 2012, Pages 426-433

  Khan, M A ^a   Dixit, K ^a   Uddin, M ^a   Malik, A ^a   Alam, K ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; AUTOANTIBODY; C REACTIVE PROTEIN; DNA; HISTONE H2A; IMMUNOGLOBULIN G; NITRITE; PEROXYNITRITE; RHEUMATOID FACTOR;

ANTIGEN BINDING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; C-REACTIVE PROTEIN; DISEASE PROGRESSION; HISTONES; HUMANS; IMMUNOGLOBULIN G; PEROXYNITROUS ACID; RHEUMATOID FACTOR; TYROSINE;

EID: 84869404934     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2012.698300     Document Type: Article

References (35)

1. Wang J, Wang G, Ansari GA, Khan MF. Activation of oxidative stress-responsive signaling pathways in early splenotoxic response of aniline. Toxicol Appl Pharmacol 2008;230:227-34.
2. Dixit K, Ali R. Role of nitric oxide modified DNA in the etiopathogenesis of systemic lupus erythematosus. Lupus 2004;13:95-100. (Pubitemid 38222353)
3. Cuzzocrea S. Role of nitric oxide and reactive oxygen species in arthritis. Curr Pharm Des 2006;12:3551-70. (Pubitemid 44400492)
4. Nagy G, Clark JM, Buzás EI, Gorman CL, Cope AP. Nitric oxide, chronic inflammation and autoimmunity. ImmunolLett 2007; 111:1-5. (Pubitemid 47017476)
5. Xia Y, Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 1997;94:6954-8. (Pubitemid 27281972)
6. Ohmori H, Kanayama N. Immunogenicity of an inflammationassociated product, tyrosine nitrated self proteins. Autoimmun Rev 2005;4:224-9. (Pubitemid 40704707)
7. Habib S, Moinuddin, Ali R. Peroxynitrite-modified DNA: A better antigen for systemic lupus erythematosus anti-DNA autoantibodies. Biotechnol Appl Biochem 2006;43:65-70.
8. Kurien BT, Hensley K, Bachmann M, Scofield RH. Oxidatively modified autoantigens in autoimmune diseases. Free Radic Biol Med 2006;41:549-56. (Pubitemid 44080517)
9. Gilkeson G, Cannon C, Oates J, Reilly C, Goldman D, Petri M. Correlation of serum measures of nitric oxide production with lupus disease activity. J Rheumatol 1999;26:318-24. (Pubitemid 29066735)
10. Oates JC, Christensen EF, Reilly CM, Self SE, Gilkeson GS. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity. Proc Assoc Am Physicians 1999;111:611-21.
11. Morgan PE, Sturgess AD, Davies MJ. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis Rheum 2005;52:2069-79. (Pubitemid 41001420)
12. Dandy DJ. Rheumatoid arthritis and other arthropathies. In Essential Orthopaedics and Trauma. London: Churchill Livingstone 1989: 289-96.
13. Stadtman ER, Berlett BS. Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab Rev 1998;30:225-43. (Pubitemid 28266861)
14. Renke J, Szlagatys A, Hansdorfer-Korzon R, Szumera M, Kamińska B, Knap N, et al. Persistence of protein oxidation products and plasma antioxidants in juvenile idiopathic arthritis. A one-year follow-up study. Clin Exp Rheumatol 2007;25:112-14. (Pubitemid 46477496)
15. Khan F, Ali R. Antibodies against nitric oxide damaged poly L-tyrosine and 3-nitrotyrosine levels in systemic lupus erythematosus. J Biochem Mol Biol 2006;39:189-96.
16. Khan F, Siddiqui AA, Ali R. Measurement and significance of 3-nitrotyrosine in systemic lupus erythematosus. Scand J Immunol 2006;64:507-14. (Pubitemid 44536335)
17. Koppenol WH, Kissner R, Beckman S. Synthesis of peroxynitrite: to go with the flow or on solid grounds? Methods Enzymol 1996;269:296-302. (Pubitemid 26295717)
18. Khan MA, Dixit K, Jabeen S, Moinuddin, Alam K. Impact of peroxynitrite modification on structure and immunogenicity of H2A histone. Scand J Immunol 2008;69:99-109.
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
20. Nicholas DJD, Nason A. Determination of nitrate and nitrite. Methods Enzymol 1975;3:982-4.
21. Kaur H, Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 1994;350:9-12.
22. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990;86:464-7.
23. Goding JW. Use of staphylococcal protein A as an immunological reagent. J Immunol Methods 1978;20:241-53. (Pubitemid 8329659)
24. Alam K, Moinuddin, Jabeen S. Immunogenicity of mitochondrial DNA modified by hydroxyl radical. Cell Immunol 2007;247: 12-17. (Pubitemid 47464176)
25. Ali R, Alam K. Evaluation of antibodies against oxygen free radicalmodified DNA by ELISA. Methods Mol Biol 2002;186:171-81.
26. Waris G, Alam K. Immunogenecity of superoxide radical modified-DNA: studies on induced antibodies and SLE anti-DNA autoantibodies. Life Sci 2004;75:2633-42. (Pubitemid 39215056)
27. Dixit K, Khan MA, Sharma YD, Moinuddin, Alam K. Peroxynitrite-induced modification of H2A histone presents epitopes which are strongly bound by human anti-DNA autoantibodies: role of peroxynitrite-modified H2A in SLE induction and progression. Human Immunol 2011;72:219-25.
28. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci USA 2004;101:4003-8. (Pubitemid 38405874)
29. Ischiropoulos H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem Biophys Res Commun 2003;305:776-83. (Pubitemid 36581936)
30. Ohmori H, Oka M, Nishikawa Y. Immunogenicity of autologous IgG bearing the inflammation-associated marker 3-nitrotyrosine. Immunol Lett 2005;96:47-54. (Pubitemid 39600759)
31. Sokolorsky M, Riordan JF, Vallee BL. Tetranitromethane. A reagent for the nitration of tyrosyl residues in protein. Biochemistry 1966;5:3582-9.
32. Beal MF. Oxidatively modified proteins in aging and disease. Free Radic Biol Med 2002;32:797-803. (Pubitemid 34439250)
33. Kurien BT, Scofield RH. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 2008;7:567-73.
34. Onur O, Akinci AS, Akbiyik F, Unsal I. Elevated levels of nitrate in rheumatoid arthritis. Rheumatol Int 2001;20:154-8. (Pubitemid 32449113)
35. Nyhall-Wahlin BM, Turesson C, Jacobsson LT, Nilsson JA, Forslind K, Albertsson K, et al. The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extraarticular disease and predicts radiographic progression of joint destruction over 5 years. Scand J Rheumatol 2011;40: 81-7.